ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Taking Over the "King of Medicine"? Chinese Enterprises Lead the Development of PD-(L)1/VEGF Bispecific Antibody Antitumor Drug
April 28, 2025PD-(L)1 and VEGF (vascular endothelial growth factor) bispecific antibody therapies are considered a key direction for future tumor treatments, attracting increasing global interest due to their unique mechanism of action and promising clinical data. -
A Review of 2016 Antitumor Drug Market: Cost Growth VS Basic Medical Security
March 10, 2017In 2016, four new antitumor drugs were approved by the FDA, and a further 12 existing antitumor agents were approved for 14 additional indications.
Pharma Sources Insight January 2025
